Development and validation of a stability-indicating RP-HPLC method for the determination of paracetamol with dantrolene or/and cetirizine and pseudoephedrine in two pharmaceutical dosage forms
Research output: Journal contributions › Journal articles › Research › peer-review
Standard
In: Talanta, Vol. 79, No. 5, 15.10.2009, p. 1360-1367.
Research output: Journal contributions › Journal articles › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Development and validation of a stability-indicating RP-HPLC method for the determination of paracetamol with dantrolene or/and cetirizine and pseudoephedrine in two pharmaceutical dosage forms
AU - Hadad, Ghada M.
AU - Emara, Samy
AU - Mahmoud, Waleed M. M.
PY - 2009/10/15
Y1 - 2009/10/15
N2 - A stability-indicating reversed-phase high-performance liquid chromatography (RP-HPLC) method has been developed which can separate and accurately quantitate paracetamol, dantrolene, cetirizine and pseudoephedrine. The method was successfully validated for the purpose of conducting stability studies of the four analytes in quality control (QC) laboratories. The stability-indicating capability of the method was demonstrated by adequate separation of these four analytes from all the degradant peaks. A gradient mobile phase system consisting of (A) 50 mmol L−1 sodium dihydrogen phosphate, 5 mmol L−1 heptane sulfonic acid sodium salt, pH 4.2 and (B) acetonitrile was used with Discovery reversed-phase HS C18 analytical column (250 mm × 4.6 mm i.d., 5 μm particle size). Quantitation was achieved with UV detection at 214 nm, based on peak area.The proposed method was validated and successfully applied for the analysis of pharmaceutical formulations and laboratory-prepared mixtures containing the two multicomponent combinations.
AB - A stability-indicating reversed-phase high-performance liquid chromatography (RP-HPLC) method has been developed which can separate and accurately quantitate paracetamol, dantrolene, cetirizine and pseudoephedrine. The method was successfully validated for the purpose of conducting stability studies of the four analytes in quality control (QC) laboratories. The stability-indicating capability of the method was demonstrated by adequate separation of these four analytes from all the degradant peaks. A gradient mobile phase system consisting of (A) 50 mmol L−1 sodium dihydrogen phosphate, 5 mmol L−1 heptane sulfonic acid sodium salt, pH 4.2 and (B) acetonitrile was used with Discovery reversed-phase HS C18 analytical column (250 mm × 4.6 mm i.d., 5 μm particle size). Quantitation was achieved with UV detection at 214 nm, based on peak area.The proposed method was validated and successfully applied for the analysis of pharmaceutical formulations and laboratory-prepared mixtures containing the two multicomponent combinations.
KW - Chemistry
KW - Cetirizine
KW - Dantrolene
KW - Paracetamol
KW - Pseudoephedrine
KW - Reversed-phase HPLC
KW - Stability
UR - http://www.scopus.com/inward/record.url?scp=67650979193&partnerID=8YFLogxK
U2 - 10.1016/j.talanta.2009.06.003
DO - 10.1016/j.talanta.2009.06.003
M3 - Journal articles
C2 - 19635371
VL - 79
SP - 1360
EP - 1367
JO - Talanta
JF - Talanta
SN - 0039-9140
IS - 5
ER -